Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010

Emerging Infectious Diseases

Volumn 19, Issue 11, 2013, Pages 1889-1891

  Marras, Theodore K ^a,b,c   Mendelson, David ^a,b,c   Marchand Austin, Alex ^c,d   May, Kevin ^d   Jamieson, Frances B ^c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATYPICAL MYCOBACTERIOSIS; CANADA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; INFECTION RATE; LUNG INFECTION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM XENOPEI; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SPECIES DIFFERENTIATION;

ATYPICAL MYCOBACTERIA; ATYPICAL MYCOBACTERIUM; BACTERIA; CANADA; EPIDEMIOLOGY; MYCOBACTERIUM AVIUM-INTRACELLULARE; MYCOBACTERIUM AVIUM-INTRACELLULARE COMPLEX; MYCOBACTERIUM INTRACELLULARE; NONTUBERCULOUS MYCOBACTERIUM; ONTARIO; TUBERCULOSIS AND OTHER MYCOBACTERIA;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; ONTARIO; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 84886998122     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1911.130737     Document Type: Article

References (16)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases [Erratum in Am J Respir Crit Care Med. 2007; 175: 744-5]. Am J Respir Crit Care Med. 2007; 175: 367-416. http://dx. doi. org/10. 1164/rccm. 200604-571ST.
2. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacterium aviumintracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest. 1999; 115: 1033-40. http://dx. doi. org/10. 1378/chest. 115. 4. 1033.
3. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest. 2004; 126: 566-81. http://dx. doi. org/10. 1378/chest. 126. 2. 566.
4. Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K, Marras TK. Aging, COPD and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest. 2012; 141: 190-7. http://dx. doi. org/10. 1378/chest. 11-0089.
5. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010; 182: 977-82. http://dx. doi. org/10. 1164/rccm. 201003-0503OC.
6. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010; 182: 970-6. http://dx. doi. org/10. 1164/rccm. 201002-0310OC.
7. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U. S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012; 185: 881-.
8. http://dx. doi. org/10. 1164/rccm. 201111-2016OC.
9. Kobashi Y, Matsushima T. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan-including a follow-up study. Respiration. 2007; 74: 394-400. http://dx. doi. org/10. 1159/000095674.
10. Marras TK, Mehta M, Chedore P, May K, AlHouqani M, Jamieson F. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung. 2010; 188: 289-99. http://dx. doi. org/10. 1007/s00408-010-9241-8.
11. Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010; 181: 514-21. http://dx. doi. org/10. 1164/rccm. 200905-0778OC.
12. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012; 185: 575-83. http://dx. doi. org/10. 1164/rccm. 201107-1203OC.
13. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009; 49: e124-9. http://dx. doi. org/10. 1086/648443.
14. Al-Houqani M, Jamieson F, Chedore P, Mehta M, May K, Marras TK. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario 2007. Can Respir J. 2011; 18: 19-24.
15. Romanus V, Hallander HO, Wahlen P, Olinder-Nielsen AM, Magnusson PHW, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG vaccination coverage. Tuber Lung Dis. 1995; 76: 300-10. http://dx. doi. org/10. 1016/S0962-8479(05)80028-0.
16. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination: 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis. 1994; 75: 348-52. http://dx. doi. org/10. 1016/0962-8479(94)90080-9.